U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07238907) titled 'A Multi-center Retrospective Study of INO Treating B-ALL' on Sept. 22.
Brief Summary: This multi-center retrospective study aims to evaluate the efficacy and safety of inotuzumab ozogamicin in adults B-ALL of different subgroups. This study is a retrospective study. Data will be collected from Electronic Medical Record, interventions will not be implemented on patients.
Study Start Date: June 01, 2022
Study Type: OBSERVATIONAL
Condition:
Acute Lymphoblastic Leukaemia
Acute Lymphoblastic Leukaemias (ALL)
Inotuzumab Ozogamicin
Venetoclax
Intervention:
DRUG: Inotuzumab Ozogamicin
All patients have received Inotuzumab Ozogamicin...